{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:42:46Z","timestamp":1792464166769,"version":"4.5.0"},"reference-count":57,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Allogeneic chimeric antigen receptor (CAR) T-cell therapies hold promise for certain malignant disorders, as they allow for scalability, on-demand availability, and enhanced product quality. Currently, allogeneic CAR T-cell approaches focus on deleting the \u03b1\u03b2 T-cell receptor complex and major histocompatibility complex (MHC)-I\/II from CAR T cells to prevent graft-versus-host disease and rejection of allogeneic cells by the recipient\u2019s immune system. However, genetic ablation of MHC-I leads to natural killer (NK) cell activation in recipients because of the missing-self response. Here, we demonstrate the successful generation of universal allogeneic CAR T (UCART) cells that evade the NK cell\u2019s missing-self response and display similar performance to autologous CAR T cells both in vitro and in vivo. An HLA single-chain trimer platform enabled the demonstration that HLA-E presentation of a defined signal peptide sequence, VMAPRTLIL (designated as HLA-ESP-1C), confers resistance to NKG2A+ cell populations with negligible activation of NKG2C+ cell populations. Examination of additional receptor-ligand interactions that may impact NK cell activation confirmed that CD54 and CD58 ablation on UCART cells, in combination with HLA-ESP-1C expression, led to optimal resistance to heterogeneous NKG2A+\/C+ NK cell populations. Finally, in a humanized mouse model reconstituted with allogeneic NK cells, we demonstrated that UCART19 cells promote stringent tumor control. Our work suggests an updated approach for allogeneic CAR T-cell therapy in clinical applications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016927","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:54:38Z","timestamp":1775588078000},"page":"4266-4280","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["HLA-E single-chain trimer shields gene-edited allogeneic CAR T cells from NK cell attack"],"prefix":"10.1182","volume":"10","author":[{"given":"Kimberly M.","family":"Apodaca","sequence":"first","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"2Biomedical Graduate Studies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Xu","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey L.","family":"Stanton","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren L.","family":"Baroja","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1892-4933","authenticated-orcid":false,"given":"Angel R.","family":"Alfaro Doblado","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3514-5686","authenticated-orcid":false,"given":"Nils W.","family":"Engel","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Wellhausen","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1841-8512","authenticated-orcid":false,"given":"Arin","family":"Cox","sequence":"additional","affiliation":[{"name":"3Comparative Pathology Core, Department of Pathology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla","family":"Berjis","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"2Biomedical Graduate Studies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Ji","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Bushara","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"2Biomedical Graduate Studies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"4Department of Surgery, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Melendez","family":"Perez","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Welch","sequence":"additional","affiliation":[{"name":"5Department of Chemistry, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7677-3702","authenticated-orcid":false,"given":"Esha","family":"Banerjee","sequence":"additional","affiliation":[{"name":"3Comparative Pathology Core, Department of Pathology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0073-2730","authenticated-orcid":false,"given":"Charles-Antoine","family":"Assenmacher","sequence":"additional","affiliation":[{"name":"3Comparative Pathology Core, Department of Pathology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-9491","authenticated-orcid":false,"given":"Neil C.","family":"Sheppard","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"6Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9725-6277","authenticated-orcid":false,"given":"John","family":"Scholler","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0241-3557","authenticated-orcid":false,"given":"Carl H.","family":"June","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"6Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"7Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8123-2035","authenticated-orcid":false,"given":"Beatriz M.","family":"Carreno","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"6Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"7Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald P.","family":"Linette","sequence":"additional","affiliation":[{"name":"1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"7Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA"},{"name":"8Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"177","key":"2026062308474512800_bib1","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci Transl Med"},{"issue":"25","key":"2026062308474512800_bib2","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood-2013-08-519413","article-title":"Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation","volume":"122","author":"Kochenderfer","year":"2013","journal-title":"Blood"},{"issue":"16","key":"2026062308474512800_bib3","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N Engl J Med"},{"key":"2026062308474512800_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","article-title":"Global manufacturing of CAR T cell therapy","volume":"4","author":"Levine","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"2026062308474512800_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"issue":"5","key":"2026062308474512800_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/2643-3230.BCD-21-0084","article-title":"Scalable manufacturing of CAR T cells for cancer immunotherapy","volume":"2","author":"Abou-El-Enein","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"6382","key":"2026062308474512800_bib7","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"issue":"374","key":"2026062308474512800_bib8","doi-asserted-by":"crossref","first-page":"eaaj2013","DOI":"10.1126\/scitranslmed.aaj2013","article-title":"Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells","volume":"9","author":"Qasim","year":"2017","journal-title":"Sci Transl Med"},{"issue":"3","key":"2026062308474512800_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.it.2021.01.004","article-title":"Taking T-cell oncotherapy off-the-shelf","volume":"42","author":"Mo","year":"2021","journal-title":"Trends Immunol"},{"issue":"8","key":"2026062308474512800_bib10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.2022016204","article-title":"Genome-edited allogeneic donor \u201cuniversal\u201d chimeric antigen receptor T cells","volume":"141","author":"Qasim","year":"2023","journal-title":"Blood"},{"issue":"7","key":"2026062308474512800_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the 'missing self': MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol Today"},{"issue":"6307","key":"2026062308474512800_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/349329a0","article-title":"Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice","volume":"349","author":"Bix","year":"1991","journal-title":"Nature"},{"issue":"3","key":"2026062308474512800_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4049\/jimmunol.141.3.897","article-title":"HLA-E. A novel HLA class I gene expressed in resting T lymphocytes","volume":"141","author":"Koller","year":"1988","journal-title":"J Immunol"},{"issue":"6","key":"2026062308474512800_bib14","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.4049\/jimmunol.149.6.1934","article-title":"The HLA class I gene family includes at least six genes and twelve pseudogenes and gene fragments","volume":"149","author":"Geraghty","year":"1992","journal-title":"J Immunol"},{"issue":"5","key":"2026062308474512800_bib15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.187.5.813","article-title":"Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94\/NKG2 confers protection from natural killer cell-mediated lysis","volume":"187","author":"Borrego","year":"1998","journal-title":"J Exp Med"},{"issue":"10","key":"2026062308474512800_bib16","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.160.10.4951","article-title":"HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences","volume":"160","author":"Lee","year":"1998","journal-title":"J Immunol"},{"issue":"3","key":"2026062308474512800_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0198-8859(92)90069-Y","article-title":"Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism","volume":"33","author":"Geraghty","year":"1992","journal-title":"Hum Immunol"},{"issue":"1","key":"2026062308474512800_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4049\/jimmunol.160.1.189","article-title":"The MHC-E locus is the most well conserved of all known primate class I histocompatibility genes","volume":"160","author":"Knapp","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"2026062308474512800_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0198-8859(96)00241-8","article-title":"Population genetic studies of HLA-E: evidence for selection","volume":"52","author":"Grimsley","year":"1997","journal-title":"Hum Immunol"},{"issue":"11","key":"2026062308474512800_bib20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0198-8859(00)00190-7","article-title":"Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells","volume":"61","author":"Maier","year":"2000","journal-title":"Hum Immunol"},{"issue":"7","key":"2026062308474512800_bib21","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1074\/jbc.M208268200","article-title":"HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities","volume":"278","author":"Strong","year":"2003","journal-title":"J Biol Chem"},{"issue":"5","key":"2026062308474512800_bib22","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/eji.1830270517","article-title":"The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9","volume":"27","author":"Braud","year":"1997","journal-title":"Eur J Immunol"},{"issue":"5455","key":"2026062308474512800_bib23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.287.5455.1031","article-title":"Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40","volume":"287","author":"Tomasec","year":"2000","journal-title":"Science"},{"issue":"10","key":"2026062308474512800_bib24","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.4049\/jimmunol.164.10.5019","article-title":"Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis","volume":"164","author":"Ulbrecht","year":"2000","journal-title":"J Immunol"},{"issue":"1","key":"2026062308474512800_bib25","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1038\/s41467-018-05459-z","article-title":"Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding","volume":"9","author":"Walters","year":"2018","journal-title":"Nat Commun"},{"issue":"6669","key":"2026062308474512800_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"issue":"9","key":"2026062308474512800_bib27","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","article-title":"HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A","volume":"95","author":"Lee","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2026062308474512800_bib28","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W","article-title":"HLA-E-bound peptides influence recognition by inhibitory and triggering CD94\/NKG2 receptors: preferential response to an HLA-G-derived nonamer","volume":"28","author":"Llano","year":"1998","journal-title":"Eur J Immunol"},{"issue":"1","key":"2026062308474512800_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4049\/jimmunol.162.1.305","article-title":"Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94\/NKG2A and NK cells","volume":"162","author":"Brooks","year":"1999","journal-title":"J Immunol"},{"issue":"13","key":"2026062308474512800_bib30","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/blood-2009-01-201632","article-title":"Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors","volume":"114","author":"Bryceson","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2026062308474512800_bib31","doi-asserted-by":"crossref","first-page":"e31959","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"2026062308474512800_bib32","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.4049\/jimmunol.1401972","article-title":"Coordinated expression of DNAM-1 and LFA-1 in educated NK cells","volume":"194","author":"Enqvist","year":"2015","journal-title":"J Immunol"},{"issue":"5428","key":"2026062308474512800_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"issue":"7054","key":"2026062308474512800_bib34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"issue":"6","key":"2026062308474512800_bib35","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.4049\/jimmunol.173.6.3653","article-title":"LFA-1 contributes an early signal for NK cell cytotoxicity","volume":"173","author":"Barber","year":"2004","journal-title":"J Immunol"},{"issue":"5","key":"2026062308474512800_bib36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1074-7613(00)80136-3","article-title":"Physical and functional association of LFA-1 with DNAM-1 adhesion molecule","volume":"11","author":"Shibuya","year":"1999","journal-title":"Immunity"},{"issue":"6","key":"2026062308474512800_bib37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0092-8674(00)80790-4","article-title":"Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors","volume":"97","author":"Wang","year":"1999","journal-title":"Cell"},{"issue":"7","key":"2026062308474512800_bib38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1471-4906(02)02243-3","article-title":"Assembly of the immunological synapse for T cells and NK cells","volume":"23","author":"Davis","year":"2002","journal-title":"Trends Immunol"},{"issue":"10","key":"2026062308474512800_bib39","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/eji.201646492","article-title":"CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection","volume":"46","author":"Rolle","year":"2016","journal-title":"Eur J Immunol"},{"issue":"12","key":"2026062308474512800_bib40","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.1074\/jbc.M709935200","article-title":"Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides","volume":"283","author":"Truscott","year":"2008","journal-title":"J Biol Chem"},{"issue":"20","key":"2026062308474512800_bib41","doi-asserted-by":"crossref","first-page":"e2427216122","DOI":"10.1073\/pnas.2427216122","article-title":"Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR\/Cas9 nuclease-engineered T cells","volume":"122","author":"Engel","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2026062308474512800_bib42","doi-asserted-by":"crossref","first-page":"e1219007","DOI":"10.1080\/2162402X.2016.1219007","article-title":"Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma","volume":"5","author":"Granzin","year":"2016","journal-title":"Oncoimmunology"},{"issue":"8","key":"2026062308474512800_bib43","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.celrep.2018.07.069","article-title":"Distinct HLA-E peptide complexes modify antibody-driven effector functions of adaptive NK cells","volume":"24","author":"Rolle","year":"2018","journal-title":"Cell Rep"},{"issue":"7","key":"2026062308474512800_bib44","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41590-023-01523-z","article-title":"HLA class I signal peptide polymorphism determines the level of CD94\/NKG2-HLA-E-mediated regulation of effector cell responses","volume":"24","author":"Lin","year":"2023","journal-title":"Nat Immunol"},{"issue":"1","key":"2026062308474512800_bib45","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1038\/s41467-023-40220-1","article-title":"High-throughput characterization of HLA-E-presented CD94\/NKG2x ligands reveals peptides which modulate NK cell activation","volume":"14","author":"Huisman","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"2026062308474512800_bib46","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Guma","year":"2004","journal-title":"Blood"},{"key":"2026062308474512800_bib47","doi-asserted-by":"crossref","first-page":"935949","DOI":"10.3389\/fimmu.2022.935949","article-title":"CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire","volume":"13","author":"Hassan","year":"2022","journal-title":"Front Immunol"},{"issue":"15","key":"2026062308474512800_bib48","doi-asserted-by":"crossref","first-page":"e150079","DOI":"10.1172\/jci.insight.150079","article-title":"Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion","volume":"7","author":"Myers","year":"2022","journal-title":"JCI Insight"},{"issue":"3","key":"2026062308474512800_bib49","doi-asserted-by":"crossref","first-page":"101566","DOI":"10.1016\/j.beha.2024.101566","article-title":"Allogeneic \u201cOff-the-Shelf\u201d CAR T cells: challenges and advances","volume":"37","author":"Chen","year":"2024","journal-title":"Best Pract Res Clin Haematol"},{"issue":"8","key":"2026062308474512800_bib50","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.3860","article-title":"HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells","volume":"35","author":"Gornalusse","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2026062308474512800_bib51","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1038\/s41467-022-30896-2","article-title":"Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing","volume":"13","author":"Jo","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"2026062308474512800_bib52","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.stem.2024.06.011","article-title":"Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies","volume":"31","author":"Hammer","year":"2024","journal-title":"Cell Stem Cell"},{"key":"2026062308474512800_bib53","doi-asserted-by":"crossref","first-page":"1052717","DOI":"10.3389\/fimmu.2022.1052717","article-title":"Simultaneous editing of TCR, HLA-I\/II and HLA-E resulted in enhanced universal CAR-T resistance to allo-rejection","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"2026062308474512800_bib54","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/eji.202049107","article-title":"Mutant B2M-HLA-E and B2M-HLA-G fusion proteins protects universal chimeric antigen receptor-modified T cells from allogeneic NK cell-mediated lysis","volume":"51","author":"Guo","year":"2021","journal-title":"Eur J Immunol"},{"issue":"1","key":"2026062308474512800_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41587-020-0601-5","article-title":"Engineered off-the-shelf therapeutic T cells resist host immune rejection","volume":"39","author":"Mo","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"8059","key":"2026062308474512800_bib56","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41586-025-08657-0","article-title":"HIV immune evasin Nef enhances allogeneic CAR T cell potency","volume":"640","author":"Perica","year":"2025","journal-title":"Nature"},{"issue":"2","key":"2026062308474512800_bib57","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/bloodadvances.2024013436","article-title":"Universal protection of allogeneic T-cell therapies from natural killer cells via CD300a agonism","volume":"9","author":"Zhang","year":"2025","journal-title":"Blood Adv"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/12\/4266\/2527412\/blooda_adv-2025-016927-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/12\/4266\/2527412\/blooda_adv-2025-016927-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:54:07Z","timestamp":1782219247000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/12\/4266\/567601\/HLA-E-single-chain-trimer-shields-gene-edited"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,6,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016927","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,23]]},"published":{"date-parts":[[2026,6,12]]}}}